Bizzaro N, Tremolada F, Casarin C, Bonetti P, Noventa F, Diodati G, Drago C, Realdi G
Servizio di Patologia Clinica, Ospedale Civile di S. Donà di Piave, Venezia, Italy.
Ital J Gastroenterol. 1992 Jun;24(5):237-41.
Serum alanine aminotransferase (ALT) activity and antibody to hepatitis B core antigen (anti-HBc) were proposed as surrogate markers of non-A, non-B (NANB) infection. In this study we analyzed 649 consecutive repeat blood donors to define the possible exclusion rate if both surrogate markers were implemented in our Blood Service, and to assess risk factors associated with elevated ALT levels. One hundred and seven blood donors (16.5%) had slightly elevated ALT levels (higher than the upper reference value, but less than twice this level), but only 15 (2.3%) had a level higher than mean log + 2.25 SD. Seventy-seven (11.8%) resulted anti-HBc positive. Blood donors with elevated ALT levels and those who were anti-HBc positive belonged to different populations, being only 6 (0.9%) positive for both surrogate markers. Only two known donors (0.3%) resulted anti-HCV positive, and each of them was implicated in one of the four post-transfusion hepatitis (PTH) cases observed in 200 recipients of blood from these 649 donors. Both were negative for anti-HBc but one had elevated ALT levels. Male sex, age, alcohol use and obesity resulted all independently and significantly associated with elevated ALT levels. For both alcohol use and body weight we observed a significant linear relationship with serum ALT levels. These findings suggest that in our Region the exclusion of blood donors with ALT levels above the reference value, or those anti-HBc positive, would exclude an unacceptably high rate of blood donors without proven evidence of post-transfusion hepatitis prevention.(ABSTRACT TRUNCATED AT 250 WORDS)
血清丙氨酸氨基转移酶(ALT)活性和乙肝核心抗原抗体(抗-HBc)被提议作为非甲非乙型(NANB)感染的替代标志物。在本研究中,我们分析了649名连续的重复献血者,以确定如果在我们的血液中心同时采用这两种替代标志物可能的排除率,并评估与ALT水平升高相关的危险因素。107名献血者(16.5%)的ALT水平略有升高(高于参考值上限,但低于该水平的两倍),但只有15名(2.3%)的水平高于均值对数+2.25标准差。77名(11.8%)抗-HBc呈阳性。ALT水平升高的献血者和抗-HBc呈阳性的献血者属于不同人群,两种替代标志物均呈阳性的仅6名(0.9%)。只有两名已知献血者(0.3%)抗-HCV呈阳性,他们分别涉及从这649名献血者中接受输血的200名受血者中观察到的4例输血后肝炎(PTH)病例之一。两人抗-HBc均为阴性,但其中一人ALT水平升高。男性、年龄、饮酒和肥胖均独立且显著地与ALT水平升高相关。对于饮酒和体重,我们均观察到与血清ALT水平存在显著的线性关系。这些发现表明,在我们地区,排除ALT水平高于参考值的献血者或抗-HBc呈阳性的献血者,将排除比例高得不可接受的献血者,而没有输血后肝炎预防的可靠证据。(摘要截选至250字)